Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001976713-24-000001
Filing Date
2024-01-02
Accepted
2024-01-02 11:02:41
Documents
1
Effectiveness Date
2024-01-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9073
  Complete submission text file 0001976713-24-000001.txt   10124
Mailing Address 119 KENDALL STREET LEXINGTON MA 02421
Business Address 119 KENDALL STREET LEXINGTON MA 02421 617-452-2603
Omnipulse Biosciences, Inc. (Filer) CIK: 0001976713 (see all company filings)

EIN.: 920449086 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-501260 | Film No.: 24500920